Cite
MLA Citation
M. Gooderham et al.. “Long‐term, durable, absolute Psoriasis Area and Severity Index and health‐related quality of life improvements with risankizumab treatment: a post hoc integrated analysis of patients with moderate‐to‐severe plaque psoriasis.” Journal of the European Academy of Dermatology and Venereology, vol. 36, 2022, pp. 855–865. http://access.bl.uk/ark:/81055/vdc_100154265851.0x00001d